Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hanover Holdings (primarily operating through Hanover Holdings I, LLC) was a private investment firm and an affiliate of the Magna Group, which served as a prominent financier for micro-cap and clinical-stage biotechnology companies. The firm specialized in providing alternative financing solutions, such as committed equity line facilities and convertible debt, to cash-strapped life science companies like Advaxis, SINTX Technologies, and Terra Tech. While these investments provided essential capital for early-stage clinical development and research, the financing structures were often controversial due to their dilutive impact on common shareholders. In recent years, the firm and its parent, Magna Group, have been subject to significant regulatory scrutiny and SEC enforcement actions regarding their financing practices and the sale of unregistered securities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hanover Holdings.